Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor

Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor

US Patent 12421236 · Granted Sep 23, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dimethylsulfoximine derivative2025
SGLT2/DPP4 inhibitor and application thereof2025
Indazole-fused cyclic compound2025
Salt form and crystal form of tetrahydrocyclohepta indazole compound2025
Benzopyrimidine compounds and use thereof2025
FGFR inhibitor compound in solid form and preparation method therefor2025
Spiro compound serving as ERK inhibitor, and application thereof2025
Preparation method for oxazepine compound2025
Pyridine derivative as FGFR and VEGFR dual inhibitors2025
Pyrrolopyrimidine compound as BTK inhibitor and use thereof2025
SGLTS/DPP4 inhibitor and application thereof2025
Compound as porcupine inhibitor and use thereof2025